Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health: Healthy Gift
05:36pm, Tuesday, 20'th Aug 2024
Hims & Hers Health, Inc. reported booming sales in Q2, but the stock fell due to possible confusion on compounded GLP-1 drug sales. The online health and wellness platform dramatically hiked Q3 sales
Hims & Hers: Great Value Amid Unwarranted Concerns (Rating Upgrade)
03:02pm, Tuesday, 20'th Aug 2024
Hims & Hers stock has dropped ~30% from recent peaks despite raising its outlook for FY24. Investors are concerned over projections for the company's weight loss compound drugs, especially if the FDA-
Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade
11:42am, Tuesday, 20'th Aug 2024
Subscriber growth reaccelerated, focus on personalized products, over 40% subscribers use personalized solutions. Stock-based compensation concern, $100M buyback program, increased marketing spend, po
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
10:06am, Tuesday, 20'th Aug 2024
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Magnificent Stocks That Are Screaming Buys in August
07:00am, Monday, 19'th Aug 2024
While the stock market has been volatile lately, quality businesses are still performing. Hims & Hers Health is profitable and rapidly expanding its subscriber base.
Is Hims & Hers Health the Best Growth Stock for You?
05:33pm, Friday, 16'th Aug 2024
Hims & Hers stock is trading based on speculation about its success with weight loss drugs. But that's a very small part of its business.
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
03:47am, Friday, 16'th Aug 2024
Novo Nordisk and Eli Lilly are currently the major players in the weight loss market. Hims & Hers Health is looking to disrupt the space by offering a lower-cost alternative.
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
07:02am, Tuesday, 13'th Aug 2024
Investors had to deal with the sudden volatility in the stock market last week after the S&P 500 erased trillions in wealth. Not to mention the additional losses suffered by the Nikkei 225 (Japan's ve
Hims & Hers Health Boosts Outlook. Is This a Golden Opportunity to Buy the Stock?
07:26am, Sunday, 11'th Aug 2024
Hims & Hers' revenue and profit metrics soared in the second quarter. Growth is expected to accelerate in the second half following the launch of the company's GLP-1 offering.
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?
10:00am, Friday, 09'th Aug 2024
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage
09:23am, Wednesday, 07'th Aug 2024
Hims just reported record Revenue, Profits, and Cash Flows, signifying improving fundamentals. This was driven by robust growth in its core offerings as well as the launch of its new Weight Loss offer
Hims & Hers Stock Crashed but This Is a Growth Machine
05:45am, Wednesday, 07'th Aug 2024
Don't overlook the 52% growth in the second quarter.
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
11:07am, Tuesday, 06'th Aug 2024
Most investors have had to worry about the accelerating sell-offs happening across the global stock markets this week, which aren't being encouraged by news from Warren Buffett's latest decisions. The
Hims & Hers Health, Inc. (HIMS) Q2 2024 Earnings Call Transcript
10:24pm, Monday, 05'th Aug 2024
Hims & Hers Health, Inc. (NYSE:HIMS ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Bill Newby - Head, IR Andrew Dudum - Co-Founder & CEO Yemi Okupe - CFO Conference
Hims & Hers Health, Inc. (HIMS) Q2 Earnings and Revenues Beat Estimates
07:01pm, Monday, 05'th Aug 2024
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to loss of $0.03 per share a year ago.
